NCT00113802 2021-08-19Study of Epratuzumab (hLL2) in Patients With Waldenstrom's MacroglobulinemiaGilead SciencesPhase 2 Terminated31 enrolled
NCT00044902 2007-12-28Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)AmgenPhase 2 Completed